Connor, Clark & Lunn Investment Management Ltd.
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1596800
VANCOUVER, A1
Position in XERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,006,687
-$1,357,538 QoQ
Shares Held
127,107
-68.8% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 238 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. XERS ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
572,598 | $36,617,642 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
721,002 | $12,949,195 | |
| 3 | ZTS |
Zoetis Inc.
|
118,491 | $8,514,763 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,811,714 | $7,627,315 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
192,766 | $6,530,911 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
231,979 | $3,361,375 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
353,983 | $2,966,377 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
95,381 | $2,347,326 |
All Filings in XERS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,006,687 | 127,107 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,364,225 | 407,625 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,310,732 | 1,058,692 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $13,827,881 | 1,698,757 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,734,568 | 1,227,959 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,236,195 | 589,471 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $580,815 | 171,332 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $236,857 | 83,108 | Shares | Sole | 2024-11-08 | |
| 2022-03-31 | $73,976 | 28,897 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||